Clinical Trial Update: Evaluation of Panel Reactive Antibody in Children Following Stage I Palliation for Hypoplastic Left Heart Syndrome

View source ↗

Summary

A clinical trial evaluating panel reactive antibody in children after Stage I palliation for Hypoplastic Left Heart Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Hypoplastic Left Heart Syndrome

Snippet

Sponsor: University of Pennsylvania | Conditions: Congenital Heart Disease | Status: COMPLETED